peptide conjugated nanoparticles anti-PD-L1 peptide-conjugated prodrug nanoparticles - peptide-coon-rapids Ultrasmall gold nanoparticles with a metallic core diameter of 2 nm Peptide Conjugated Nanoparticles: Revolutionizing Biomedical Applications

peptide-de-collagene-ou-collagene-marin Peptide conjugated nanoparticles represent a groundbreaking advancement in the field of nanomedicine, offering a versatile and powerful platform for a wide array of biomedical applications. These sophisticated systems leverage the unique properties of both peptides and nanoparticles, creating synergistic effects that enhance efficacy, targeting, and overall therapeutic outcomes.作者：CY Yeh·2016·被引用次数：179—Peptides are excellent alternative targeting agents for cancers, and they may alleviate some of the problems facing antibodies. Coupling targeting peptide SP204 ... The conjugation of peptides to nanoparticles has recently emerged as a versatile tool for biomedical applications, promising significant improvements in drug delivery, diagnostics, and disease treatment.作者：W Jeong·2018·被引用次数：235—Peptide–nanoparticle conjugates (PNCs)have recently emerged as a versatile tool for biomedical applications. Synergism between the two ...

The core principle behind peptide conjugated nanoparticles lies in the ability of peptides to act as highly specific targeting ligands. Unlike larger biomolecules like antibodies, peptides are generally smaller, more stable, and easier to synthesize, making them excellent alternative targeting agents for cancers and other diseases. This specificity allows for the precise delivery of therapeutic payloads or imaging agents directly to diseased sites, minimizing off-target effects and improving patient safety作者：S Kim·2024·被引用次数：39—By conjugation with peptides,PNCs can improve, control, or refine the performance of nanoparticle systemstailored for cancer theranostics [34] .... For instance, nanoparticles conjugated with K237-(HTMYYHHYQHHL) peptides have been developed for tumor neovasculature targeting drug delivery, showcasing the targeted approach. Furthermore, research into ultrasmall gold nanoparticles with a metallic core diameter of 2 nm that are surface-conjugated with peptides demonstrates the potential for precise interaction with specific epitopes作者：I Gessner·2020·被引用次数：239—In this review, we have updated the recent advances in the field of CPP-NPs, focusing on synthesis strategies, elucidating the influence of different ....

These peptide conjugated nanoparticles are not merely passive carriers; they are engineered systems designed for enhanced performance.Nanoparticles Modified with Cell-Penetrating Peptides The conjugation process itself can be tailored to optimize the interaction between the peptide and the nanoparticle surface. Strategies such as the conjugation of peptide onto NPs after particle formation (post-conjugation) are commonly employed. The resulting peptide-nanoparticle conjugates are a new material composed of natural and synthetic structural units, fusing the unique properties of peptides and nanoparticles. This approach allows for the development of promising platforms for biomedical applications such as drug/gene delivery, targeting, sensing, and imaging.Peptide-Nanoparticles Conjugates Services - CD Bioparticles

The applications of peptide conjugated nanoparticles are diverse and continually expanding作者：T Ruks·2021·被引用次数：41—Ultrasmall gold nanoparticles with a metallic core diameter of 2 nmwere surface-conjugated with peptides that selectively target epitopes .... In drug delivery, they can significantly enhance the targeting of the drug, concentrating it in the target tissue and thereby improving therapeutic efficacy while reducing systemic toxicity. This is particularly relevant for challenging diseases like cancer, where targeted therapies are crucial. For example, anti-PD-L1 peptide-conjugated prodrug nanoparticles are being developed to overcome obstacles in current cancer immunotherapy. Similarly, peptide-conjugated LNPs that can enable mRNA delivery to the neural retina are expanding the utility of LNP-mRNA therapies for inherited retinal diseases.作者：X Yu·2016·被引用次数：37—The emerging albuminnanoparticlebrings new hope for the delivery of antitumor drugs. However, a lack of robust tumor targeting greatly limits its application.

Beyond drug delivery, peptide conjugated nanoparticles are proving invaluable for diagnostic and imaging purposes. The ability to selectively target diseased cells or tissues means that these nanoparticles can be functionalized with contrast agents for enhanced molecular imaging. Studies focusing on peptide-conjugated nanoparticles for targeted photodynamic therapy highlight their potential in this area. The SP204 peptide, for instance, is useful for specific targeting of tumor cells to treat prostate cancer and to facilitate molecular imaging作者：BD Ilieş·2024·被引用次数：22—Peptides conjugated nanoparticles (NPs) arepromising platforms for biomedical applicationssuch as drug/gene delivery, targeting, sensing, and ....

The development of these advanced nanocarriers is supported by ongoing research into various nanoparticle types and conjugation strategies. Ultrasmall gold nanoparticles with a metallic core diameter of 2 nm are one example, but other materials are also being exploredGold Nanoparticle-Conjugated Peptide Synthesis. Solid lipid nanoparticles (SLNs) conjugated with a C-peptide derived from endostatin are being developed to target integrin αvβ3.作者：V Känkänen·2025·被引用次数：1—The most common approach in the literature appears to beconjugation of peptide onto NPsafter particle formation (post-conjugation). This ... Peptide-conjugated iron oxide nanoparticles are also being investigated for their ability to locally convert alternating magnetic fields, suggesting potential therapeutic applications. Companies offer custom gold nanoparticle peptide conjugation services utilizing various types of gold nanoparticles, underscoring the commercial interest and development in this area.

The safety and efficacy of these systems are paramount2024年3月29日—Peptides conjugated nanoparticles (NPs) arepromising platforms for biomedical applicationssuch as drug/gene delivery, targeting, sensing, and imaging.. AT1-HSA-MRN-NPs are safe for in vivo use and exhibit superior targeting and drug delivery characteristics for the treatment of heart failure, demonstrating the potential for therapeutic applications beyond oncology. The field of peptide-nanoparticle conjugates has recently emerged as a powerful tool for biomedical applications, enabling the treatment, diagnosis, and prevention of diseasesThenanoparticleswere surface-functionalized with hydrophilic DOTA chelates and also used as a scaffold for the targetingpeptidegrafting. In vitro .... Researchers are continuously exploring emerging technologies in the field of PNCs to refine these platforms and unlock their full potential. The synergy between peptides and nanoparticles allows PNCs to improve, control, or refine the performance of nanoparticle systems tailored for various therapeutic and diagnostic needs.Peptide-Conjugated Ultrasmall Gold Nanoparticles (2 nm) for ...

In summary, peptide conjugated nanoparticles represent a sophisticated and highly promising frontier in biomedical science作者：BD Ilieş·2024·被引用次数：22—Peptides conjugated nanoparticles (NPs) arepromising platforms for biomedical applicationssuch as drug/gene delivery, targeting, sensing, and .... Their ability to precisely target diseased sites, deliver therapeutic agents, and enable advanced imaging techniques positions them as a critical component in the future of medicine. The ongoing innovation in peptide conjugation and nanoparticle design ensures that these advanced systems will continue to drive significant advancements in healthcarePeptide-Drug Conjugation (PDC).